Showing 2751-2760 of 3315 results for "".
- Mitotech Granted Orphan Drug Designation by FDA for Visomitin in LHONhttps://modernod.com/news/mitotech-granted-orphan-drug-designation-by-fda-for-visomitin-in-lhon/2480520/Luxembourg-based Mitotech SA announced that the FDA has granted orphan drug designation (ODD) for the company’s topical cardiolipin peroxidation inhibitor, Visomitin, for the treatment of Leber’s Hereditary Optic Neuropathy (LHON), a rare inherited condition that can lead to blin
- Aramis Biosciences Launches to Address Unmet Needs in Ocular Immunologyhttps://modernod.com/news/aramis-biosciences-launches-to-address-unmet-needs-in-ocular-immunology/2480514/Aramis Biosciences announced its launch and the completion of a $10.5 million Series A financing led by Safar Partners with a strategic investment from a global leader in ophthalmic pharmaceuticals. Proceeds from the financing will be used to advance the company’s pipeline, including i
- Kubota Vision Announces Publication in Scientific Reports of Study Data for Wearable Myopia-Control Devicehttps://modernod.com/news/kubota-vision-announces-publication-in-scientific-reports-of-study-data-for-wearable-myopia-control-device/2480478/Kubota Vision announced the publication of a new paper in the journal Scientific Reports: Effect of short-term peripheral myopic defocus on ocular biometrics using Fresnel “press-on” lenses in humans. The paper
- CooperCompanies Announces Executive Management Changeshttps://modernod.com/news/coopercompanies-announces-executive-management-changes/2480477/CooperCompanies announced two senior leadership changes that will enable the company to maximize current and future opportunities. Effective February 1, 2022, Dan McBride, Executive Vice President (EVP), Chief Operating Off
- Inspecs Acquires Hardy Amies Brandhttps://modernod.com/news/inspecs-acquires-hardy-amies-brand/2480476/Inspecs, a designer, manufacturer and distributor of eyewear frames and lenses, has announced the acquisition of the Hardy Amies brand, including all global intellectual property rights. Terms of the deal were not disclosed. Hardy Amies was founded by Sir Hardy Amie
- Zeiss Celebrates 175 Years in Opticshttps://modernod.com/news/zeiss-celebrates-175-years-in-optics/2480468/This year, Zeiss celebrates its 175th year in business. Since the early days when Carl Zeiss created his first microscope, Zeiss has played a leading role in advancing the field of optics. From pioneering surgical microscopes and slit lamps, to developing optical glass and precision eye
- Centricity Vision Names Todd Pinkney Chief Commercial Officer; Launches New Campaign for Zepto Cataract Surgical Platformhttps://modernod.com/news/centricity-vision-names-todd-pinkney-chief-commercial-officer-launches-new-campaign-for-zepto-cataract-surgical-platform/2480437/Centricity Vision announced that Todd Pinkney has been named chief commercial officer (CCO) and will lead global commercialization of the Zepto Platform. "We're confident that Zepto will have a huge impact on the cataract surgery market," Mr. Pinkney said.
- Opus Genetics Announces Agreement with Massachusetts Eye and Ear and Harvard Medical School to License Third Program for Inherited Retinal Diseasehttps://modernod.com/news/opus-genetics-announces-agreement-with-massachusetts-eye-and-ear-and-harvard-medical-school-to-license-third-program-for-inherited-retinal-disease/2480431/Opus Genetics, a gene therapy company developing treatments for orphan inherited retinal diseases, announced an agreement to license its third preclinical program to address mutations in the NMNAT1 gene, which cause a specific form of Leber congenital amaurosis (LCA), from Massa
- CooperVision Myopia Control Research Receives Garland W. Clay Awardhttps://modernod.com/news/coopervision-myopia-control-research-receives-garland-w-clay-award/2480405/The American Academy of Optometry has awarded the 2021 Garland W. Clay Award to a team of researchers studying the effectiveness of CooperVision MiSight 1 day contact lenses in slowing the progression of myopia in children (aged 8-12 at the initiation of treatment).
- Alcon Inaugurates Company’s Largest European Eye Health Education and Training Center in Barcelonahttps://modernod.com/news/alcon-inaugurates-companys-largest-european-eye-health-education-and-training-centre-in-barcelona/2480404/Alcon officially opened the new Alcon Experience Center (AEC) in Barcelona, one of Europe's largest eye health education and training facilities, offering eye care professionals the opportunity to learn and gain hands-on experience with the latest innovations in ophthalmology and optometry. T